Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bioman1
    Member
    • May 2012
    • 80

    #1

    Varscan-output interpretation

    Hi all,

    I am new to NGS analysis. I have used bowtie (ver:bowtie-0.12.7) for aligning reference sequence (fastq format) with two paired end files of illumina reads (fastq format).
    I used SAM tools (ver:samtools-0.1.18) and made a 'mpileup' file.
    Then I have used Varscan (ver:.v2.2.11) for variant calling. I used "mpileup2snp" command (with default parameters) to determine SNV and for heterozygosity & homozygosity.
    My basic idea is to call heterozygous SNV with conservative filters, such as coverage, variant allele
    frequency, strand representation and p-value to isolate high-confidence calls.

    Using the command "mpileup2snp", I got the output as follows. Given 1 column as an example
    Chrom - gi|371443199|gb|JH556661.1|
    Position - 2594265
    Ref- G
    Var- C
    Cons:Cov:Reads1:Reads2:Freq:P-value- S:21:14:7:33.33%:4.3101E-3
    StrandFilter:R1+:R1-:R2+:R2-val- Fail:12:2:0:7:3.096E-4
    SamplesRef- 0
    SamplesHet- 1
    SamplesHom- 0
    SamplesNC - 0
    Cons:Cov:Reads1:Reads2:Freq:P-value- S:21:14:7:33.33%:4.3101E-3

    1.Please let me know whether I am using the correct command to call heterzygous SNV with high-confidence calls(whether I have to use mpileup2snp or mpileup2indel or mpileup2cns?)

    2.Can I parse these variant call by chromosome?. How Can I do that?

    3.Is it possible to view regions of high and low heterozygosity in the genome?. If possible, how can I do that?

    Thanks in advance

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...